Report cover image

Inflammatix Inc - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Nov 11, 2025
Length 40 Pages
SKU # GBDT20580434

Description

SummaryInflammatix Inc (Inflammatix) is a molecular diagnostics company developing host response-based diagnostic tests that read the immune system to resolve major clinical and public health challenges. The company's pipeline products include TriVerity to diagnose infection, pragnose severity; BacVerity to diagnose bacterial, viral or no infection; Mycardial Infraction for the treatment of myocardial injury; RespVerity treats pathogen identification. It markets its products under the brands TriVerity, BacVerity and RespVerity. It also carries out the activities in clinical trials and research collaborations. Inflammatix is headquartered in Burlingame, California, the US.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Inflammatix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

40 Pages
Inflammatix Inc Company Overview
Inflammatix Inc Company Snapshot
Inflammatix Inc Pipeline Products and Ongoing Clinical Trials Overview
Inflammatix Inc – Pipeline Analysis Overview
Inflammatix Inc - Key Facts
Inflammatix Inc - Major Products and Services
Inflammatix Inc Pipeline Products by Development Stage
Inflammatix Inc Pipeline Products Overview
CoVerity COVID-19 Severity Test
CoVerity COVID-19 Severity Test Product Overview
Diagnostic Test - Acute Solid-Organ Transplant Rejection
Diagnostic Test - Acute Solid-Organ Transplant Rejection Product Overview
Diagnostic Test - Dengue
Diagnostic Test - Dengue Product Overview
Diagnostic Test - Myocardial Infarction
Diagnostic Test - Myocardial Infarction Product Overview
FluVID-HR
FluVID-HR Product Overview
HostDx FeverFlu
HostDx FeverFlu Product Overview
HostDx TROPICAL FEVER
HostDx TROPICAL FEVER Product Overview
HostDxEndotypes
HostDxEndotypes Product Overview
HostDxINSEP
HostDxINSEP Product Overview
HostDxTNFresponse
HostDxTNFresponse Product Overview
Myrna Test System
Myrna Test System Product Overview
ViraBac EZ Test
ViraBac EZ Test Product Overview
ViraBac+
ViraBac+ Product Overview
Inflammatix Inc - Key Competitors
Inflammatix Inc - Key Employees
Inflammatix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Inflammatix Inc, Recent Developments
Sep 02, 2025: Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of Triverity Test System
Aug 04, 2025: Inflammatix’s Triverity Test Secures NTAP Reimbursement From CMS for First-In-Class Severity Score Working in Concert With Bacterial and Viral Insights
May 06, 2025: FDA Clears Acute Infection and Sepsis Test
Mar 25, 2025: Inflammatix Ships Triverity Test Cartridges and Myrna Instruments to the U.S. Military
Feb 05, 2025: FDA Clears Sepsis Test That Significantly Reduces Life-Or-Death Diagnosis Time
Jan 21, 2025: Inflammatix Receives FDA Clearance for First-in-Class TriVerity Test
Jan 20, 2025: Inflammatix Receives FDA 510(k) Clearance for TriVerity
Nov 12, 2024: Inflammatix begins trial evaluating mRNA test for patient infection status
Nov 29, 2023: Inflammatix receives breakthrough device designation for TriVerity system
Nov 15, 2023: Inflammatix Completes Technical Development for Triverity Acute Infection and Sepsis Test System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Inflammatix Inc Pipeline Products and Ongoing Clinical Trials Overview
Inflammatix Inc Pipeline Products by Equipment Type
Inflammatix Inc Pipeline Products by Indication
Inflammatix Inc, Key Facts
Inflammatix Inc, Major Products and Services
Inflammatix Inc Number of Pipeline Products by Development Stage
Inflammatix Inc Pipeline Products Summary by Development Stage
CoVerity COVID-19 Severity Test - Product Status
CoVerity COVID-19 Severity Test - Product Description
Diagnostic Test - Acute Solid-Organ Transplant Rejection - Product Status
Diagnostic Test - Acute Solid-Organ Transplant Rejection - Product Description
Diagnostic Test - Dengue - Product Status
Diagnostic Test - Dengue - Product Description
Diagnostic Test - Myocardial Infarction - Product Status
Diagnostic Test - Myocardial Infarction - Product Description
FluVID-HR - Product Status
FluVID-HR - Product Description
HostDx FeverFlu - Product Status
HostDx FeverFlu - Product Description
HostDx TROPICAL FEVER - Product Status
HostDx TROPICAL FEVER - Product Description
HostDxEndotypes - Product Status
HostDxEndotypes - Product Description
HostDxINSEP - Product Status
HostDxINSEP - Product Description
HostDxTNFresponse - Product Status
HostDxTNFresponse - Product Description
Myrna Test System - Product Status
Myrna Test System - Product Description
ViraBac EZ Test - Product Status
ViraBac EZ Test - Product Description
ViraBac+ - Product Status
ViraBac+ - Product Description
Inflammatix Inc, Key Employees
Inflammatix Inc, Other Locations
Glossary
List of Figures
Inflammatix Inc Pipeline Products by Equipment Type
Inflammatix Inc Pipeline Products by Development Stage

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us